Roivant Sciences Ltd.

ROIV ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Aug 18, 2026
144 Aug 17, 2026
144 Aug 14, 2026
SCHEDULE 13G/A Aug 13, 2026
10-Q Aug 6, 2026 10-Q
8-K Aug 6, 2026 8-K
4 Jul 29, 2026 FORM 4
ARS Jul 29, 2026 ARS
DEFA14A Jul 29, 2026 DEFA14A
DEF 14A Jul 29, 2026 DEF 14A
144 Jul 27, 2026
4 Jul 21, 2026 FORM 4
4 Jul 21, 2026 FORM 4
4 Jul 21, 2026 FORM 4
4 Jul 2, 2026 FORM 4
4 Jul 2, 2026 FORM 4
4 Jul 2, 2026 FORM 4
4 Jul 2, 2026 FORM 4
4 Jul 1, 2026 FORM 4
4 Jun 30, 2026 4
4 Jun 30, 2026 4
4 Jun 30, 2026 4
144 Jun 30, 2026
144 Jun 30, 2026
4 Jun 29, 2026 FORM 4
← Newer Page 3 of 40 · 993 filings Older →